Otsuka Pharmaceutical Factory and Lilium Otsuka sign Japanese-market sales partnership agreement for the medical device “Lilium® α-200”[PDF]
By indicating the proper timing for CIC (Clean Intermittent Self-Catheterization) and urination, Lilium® α-200 supports patients using CIC who previously lost the urge to urinate.
By evaluating bladder function after removal of indwelling bladder catheters in patient with postoperative-intra pelvic-surgery, Lilium® α-200 can provide suggest an appropriate timing of urination.
Lilium® α-200 can be used as a bladder function evaluation tool for patients such as those using diapers or with indwelling catheters. Self-awareness of residual urine volume may help patients to retrain after loss of urination urge.
Urine volume is displayed in figures and graphs.
Notifies with sound and vibration when the
measurement reaches a
pre-set target volume.
and easy to hold.
Keeps records of time, volume, post-void residual and level of urge.
Prints out measurement results easily by connecting with the dedicated printer via Bluetooth wireless.
Comes with useful clips, carrying pouch and more.
We launched “Lilium® α-200" in the Japanese market.
We held a press conference.
Our first product “Lilium® α-200" to be launched in the Japanese market.[PDF]
"Lilium® α-200" certified as a medical device by notified body of BSI. (British Standards Institution)
Permission as a Second Class Medical Equipment Marketing Authorization Holders.
We have been registered as a manufacturer of medical devices.
We have signed a licensing agreement contract with the AIST on patent implementation.[PDF]